PMID: 9552508Sep 1, 1996Paper

Molecular strategies to inhibit restenosis: modulation of the vascular myocyte phenotype

Seminars in Interventional Cardiology : SIIC
K Walsh, H Perlman

Abstract

The transduction of vascular myocytes with exogenous genetic material will be a common feature of many gene-based therapies for cardiovascular disorders. Therefore, the successful application of cardiovascular gene therapy will require a thorough understanding of the molecular biology of the smooth muscle cell. Of key importance are the transcriptional regulatory events that coordinate the de-differentiation and proliferation of myocytes in response to vascular injury. The goal of this review is to highlight what is known about the regulators of vascular myocyte transcription that may serve as candidate genes for the development of genetic strategies to manage postinterventional restenosis.

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Related Papers

Journal of Clinical Apheresis
R C Smith, K Walsh
Current Cardiology Reports
R C Smith, K Walsh
Acta Physiologica Scandinavica
R C Smith, K Walsh
Seminars in Interventional Cardiology : SIIC
M W Chang, J M Leiden
© 2022 Meta ULC. All rights reserved